Post date September 15, 2023 Experience Baldwin Risk Partners $170 million incremental term loan facility We advised the borrower on the amendment
Post date September 12, 2023 Experience Marsh McLennan $1.6 billion senior notes offering We advised Marsh McLennan on its investment-grade notes offering
Post date March 9, 2023 Experience Marsh McLennan $600 million senior notes offering We advised Marsh McLennan on its investment-grade notes offering
Post date March 7, 2023 Experience VF €1 billion senior notes offering, including €500 million in green bonds We advised VF on the investment-grade debt offering
Post date February 10, 2023 Experience CureVac $250 million follow-on offering We advised CureVac on the equity offering
Post date February 7, 2023 Experience Roivant Sciences $230 million stock offering We advised the company on its SEC-registered offering
Post date January 27, 2023 Experience Pacific Biosciences $201.25 million follow-on offering The shares are listed on the Nasdaq Global Select Market
Post date November 10, 2022 Experience Roivant Sciences $150 million equity offering We advised the company on its debut SEC-registered primary and secondary offering
Post date October 31, 2022 Experience Marsh McLennan $1 billion senior notes offering We advised Marsh McLennan on its investment-grade notes offering
Post date September 19, 2022 Experience Roivant Sciences $400 million at-the-market offering We advised the company on an SEC-registered at-the-market offering